DE69921530D1 - Behandlung einer Virusinfektion bei Schweinen - Google Patents

Behandlung einer Virusinfektion bei Schweinen

Info

Publication number
DE69921530D1
DE69921530D1 DE69921530T DE69921530T DE69921530D1 DE 69921530 D1 DE69921530 D1 DE 69921530D1 DE 69921530 T DE69921530 T DE 69921530T DE 69921530 T DE69921530 T DE 69921530T DE 69921530 D1 DE69921530 D1 DE 69921530D1
Authority
DE
Germany
Prior art keywords
treatment
pigs
virus infection
tilmicosin
swine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69921530T
Other languages
English (en)
Other versions
DE69921530T2 (de
Inventor
Gregory Alan Armbruster
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE69921530D1 publication Critical patent/DE69921530D1/de
Publication of DE69921530T2 publication Critical patent/DE69921530T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69921530T 1998-03-02 1999-03-01 Behandlung einer Virusinfektion bei Schweinen Expired - Lifetime DE69921530T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7646698P 1998-03-02 1998-03-02
US76466P 1998-03-02

Publications (2)

Publication Number Publication Date
DE69921530D1 true DE69921530D1 (de) 2004-12-09
DE69921530T2 DE69921530T2 (de) 2005-10-27

Family

ID=22132217

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69921530T Expired - Lifetime DE69921530T2 (de) 1998-03-02 1999-03-01 Behandlung einer Virusinfektion bei Schweinen

Country Status (16)

Country Link
US (1) US6034070A (de)
EP (1) EP0948967B1 (de)
JP (1) JP4555472B2 (de)
AT (1) ATE281173T1 (de)
AU (1) AU2979899A (de)
CA (1) CA2322327C (de)
CO (1) CO5080775A1 (de)
DE (1) DE69921530T2 (de)
DK (1) DK0948967T3 (de)
ES (1) ES2230802T3 (de)
MY (1) MY124071A (de)
PT (1) PT948967E (de)
SI (1) SI0948967T1 (de)
TW (1) TW565452B (de)
WO (1) WO1999044619A1 (de)
ZA (1) ZA991641B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506885B1 (en) * 2001-09-27 2003-01-14 The United States Of America As Represented By The Secretary Of Agriculture Monoclonal antibodies to the drug tilmicosin and a method for detecting the same
US6946137B2 (en) * 2001-10-19 2005-09-20 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
WO2003034988A2 (en) * 2001-10-19 2003-05-01 Idexx Laboratories, Inc. Injectable compositions for the controlled delivery of pharmacologically active compound
SI1483251T1 (sl) 2002-03-12 2010-03-31 Bristol Myers Squibb Co C cian epotilonski derivati
US7282487B2 (en) * 2004-10-28 2007-10-16 Idexx Laboratories Method for treating bacterial infections in horses or pigs with tilmicosin
KR101538599B1 (ko) 2006-07-28 2015-07-21 인터벳 인터내셔널 비.브이. 마크롤라이드 합성 방법
CN103288904B (zh) * 2013-06-28 2015-07-15 宁夏泰瑞制药股份有限公司 一种磷酸替米考星晶体的制备方法
CN103483406A (zh) * 2013-09-25 2014-01-01 宁夏泰瑞制药股份有限公司 一种磷酸替米考星的制备方法
CN103923141B (zh) * 2014-04-21 2016-04-27 西南大学 一种依托替米考星的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820695A (en) * 1982-09-13 1989-04-11 Eli Lilly And Company C-20-dihydro-deoxy-(cyclic amino)-derivatives of macrolide antibiotics
IL69666A (en) * 1982-09-13 1987-10-20 Lilly Co Eli 20-amino-20-deoxo-5-o-mycaminosyl-23-o-mycinosyltylonolide derivatives,their preparation and veterinary antibiotic use
US5574020A (en) * 1989-09-28 1996-11-12 Eli Lilly And Company Tilmicosin formulation
US5695766A (en) * 1992-10-30 1997-12-09 Iowa State University Research Foundation Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
GB2289279B (en) * 1994-05-13 1998-09-16 Iberica Cyanamid Diagnostic kits and vaccines containing recombinant PRRSV proteins
DK0732340T3 (da) * 1995-03-14 2004-10-25 Akzo Nobel Nv Ekspression af porcine reproduktions- og respirationssyndromviruspolypeptider i den samme celle

Also Published As

Publication number Publication date
PT948967E (pt) 2005-02-28
US6034070A (en) 2000-03-07
AU2979899A (en) 1999-09-20
JP4555472B2 (ja) 2010-09-29
DE69921530T2 (de) 2005-10-27
JP2002505294A (ja) 2002-02-19
DK0948967T3 (da) 2005-02-14
MY124071A (en) 2006-06-30
CO5080775A1 (es) 2001-09-25
WO1999044619A1 (en) 1999-09-10
SI0948967T1 (en) 2005-06-30
EP0948967A3 (de) 1999-10-20
ZA991641B (en) 2000-09-01
ATE281173T1 (de) 2004-11-15
EP0948967A2 (de) 1999-10-13
CA2322327C (en) 2009-12-22
TW565452B (en) 2003-12-11
EP0948967B1 (de) 2004-11-03
CA2322327A1 (en) 1999-09-10
ES2230802T3 (es) 2005-05-01

Similar Documents

Publication Publication Date Title
BR0309581A (pt) Derivados de nucleosìdeo para tratamento de infecção por vìrus de hepatite c
AP1782A (en) Use of compounds ?-D or ?-L nucleoside for treating hepatitis C virus.
ATE295355T1 (de) Trisubstituierte 1,3,5-triazine derivate zur behandlung von hiv infektionen
CO5210911A1 (es) Trifluorbutenos nematicidas
DE60031396D1 (de) Zubereitung zur behandlung von einer neurologischen erkrankung
ATE264846T1 (de) Substituierte benzimidazol-derivaten und ihre verwendung zur behandlung retroviraler infektionen
EA200000840A1 (ru) Антивирусные производные пиримидина
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
HK1033463A1 (en) 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
BR9909668A (pt) Uso de compostos de organofósforo para o tratamento terapêutico e profilático de infecções
DE60023043T2 (de) (S,S)-Reboxetin zur Behandlung von Inkontinenz
PT768086E (pt) Tratamento de tinido utilizando agentes neuroprotectores
DK1109817T3 (da) Phosphohalogenhydriner, deres fremstilling og anvendelse
DE69921530D1 (de) Behandlung einer Virusinfektion bei Schweinen
DK0750616T3 (da) Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelser
DE69923338D1 (de) Kombinationstherapie zur behandlung von hepatitis b infektionen
ID21874A (id) Penggunaan 1-hidroksi-2-piridon untuk pengobatan infeksi urap kulit
ATE129250T1 (de) Carboxamidderivate.
PT98268A (pt) Processo para a preparacao de indano-pirrolidino-carbamatos
NO965591D0 (no) Kombinasjonsbehandling av HIV-infeksjon
PT821955E (pt) Uso de 3-(4-hexiloxi-1,2,5-tiadiazol-3-il)-1,2,5,6-tetrahidro-1-metilpiridina (xanomelina) para o tratamento da doenca bipolar
EA200001065A1 (ru) Применение фосфорорганических соединений для терапевтического и профилактического лечения инфекций
KR950022792U (ko) 시술용 수지침의 소독기
IT9084941A0 (it) Aspiratore depuratore per il trattamento dell'aria
ES2107281T3 (es) Nuevos derivados de acetaldehido, su procedimiento de preparacion y su aplicacion.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN